TNFα Monoclonal Antibody for Acute Spinal Cord Injury

NCT04988425 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

DRUG: TNFα Monoclonal Antibody
DRUG: Methylprednisolone
DRUG: Saline

Sponsor

Shanghai Changzheng Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]